A Phase 1b, Open-Label, Dose-Escalation Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Treatment-Naive, Stage IIIB/IV Non-Small Cell Lung Cancer
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007177/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine whether BIIB022, Paclitaxel and Carboplatin are
effective in the treatment of Treatment-Naive, Stage IIIB/IV Non-Small Cell Lung Cancer.
提供机构：
Vivli
创建时间：
2021-06-10
